The global Female Contraceptive market was valued at US$ 18390 million in 2023 and is anticipated to reach US$ 22120 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.

Female Contraceptive Market

Female contraceptives, also known as female birth control are methods of preventing pregnancy that primarily involve the female physiology.

Female contraceptive devices account for major shares of the contraceptive pills market throughout the forecast period. The increasing adoption of female contraceptive devices will drive the growth of this product segment in the female contraceptive market.

This report aims to provide a comprehensive presentation of the global market for Female Contraceptive, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Female Contraceptive.

Report Scope

The Female Contraceptive market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Female Contraceptive market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Female Contraceptive manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Female Contraceptive Market Report

Report Metric	Details
Report Name	Female Contraceptive Market
Accounted market size in 2023	US$ 18390 million
Forecasted market size in 2030	US$ 22120 million
CAGR	2.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Female Contraceptive Devices Female Contraceptive Drugs
Segment by Application	Online Stores Retail Outlets
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare, Teva Pharmaceuticals, Ansell, Ferring Pharmaceuticals, Fuji Latex, Janssen Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Female Contraceptive manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Female Contraceptive in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Female Contraceptive Market growing?

Ans: The Female Contraceptive Market witnessing a CAGR of 2.6% during the forecast period 2024-2030.

What is the Female Contraceptive Market size in 2030?

Ans: The Female Contraceptive Market size in 2030 will be US$ 22120 million.

Who are the main players in the Female Contraceptive Market report?

Ans: The main players in the Female Contraceptive Market are Merck, Pfizer, Allergan, Bayer, Okamoto Industries, Reckitt Benckiser, Lupin Pharmaceuticals, Foundation Consumer Healthcare, Teva Pharmaceuticals, Ansell, Ferring Pharmaceuticals, Fuji Latex, Janssen Pharmaceuticals

What are the Application segmentation covered in the Female Contraceptive Market report?

Ans: The Applications covered in the Female Contraceptive Market report are Online Stores, Retail Outlets

What are the Type segmentation covered in the Female Contraceptive Market report?

Ans: The Types covered in the Female Contraceptive Market report are Female Contraceptive Devices, Female Contraceptive Drugs

1 Female Contraceptive Market Overview

1.1 Product Overview and Scope of Female Contraceptive

1.2 Female Contraceptive Segment by Type

1.2.1 Global Female Contraceptive Market Value Comparison by Type (2024-2030)

1.2.2 Female Contraceptive Devices

1.2.3 Female Contraceptive Drugs

1.3 Female Contraceptive Segment by Application

1.3.1 Global Female Contraceptive Market Value by Application: (2024-2030)

1.3.2 Online Stores

1.3.3 Retail Outlets

1.4 Global Female Contraceptive Market Size Estimates and Forecasts

1.4.1 Global Female Contraceptive Revenue 2019-2030

1.4.2 Global Female Contraceptive Sales 2019-2030

1.4.3 Global Female Contraceptive Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Female Contraceptive Market Competition by Manufacturers

2.1 Global Female Contraceptive Sales Market Share by Manufacturers (2019-2024)

2.2 Global Female Contraceptive Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Female Contraceptive Average Price by Manufacturers (2019-2024)

2.4 Global Female Contraceptive Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Female Contraceptive, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Female Contraceptive, Product Type & Application

2.7 Female Contraceptive Market Competitive Situation and Trends

2.7.1 Female Contraceptive Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Female Contraceptive Players Market Share by Revenue

2.7.3 Global Female Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Female Contraceptive Retrospective Market Scenario by Region

3.1 Global Female Contraceptive Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Female Contraceptive Global Female Contraceptive Sales by Region: 2019-2030

3.2.1 Global Female Contraceptive Sales by Region: 2019-2024

3.2.2 Global Female Contraceptive Sales by Region: 2025-2030

3.3 Global Female Contraceptive Global Female Contraceptive Revenue by Region: 2019-2030

3.3.1 Global Female Contraceptive Revenue by Region: 2019-2024

3.3.2 Global Female Contraceptive Revenue by Region: 2025-2030

3.4 North America Female Contraceptive Market Facts & Figures by Country

3.4.1 North America Female Contraceptive Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Female Contraceptive Sales by Country (2019-2030)

3.4.3 North America Female Contraceptive Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Female Contraceptive Market Facts & Figures by Country

3.5.1 Europe Female Contraceptive Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Female Contraceptive Sales by Country (2019-2030)

3.5.3 Europe Female Contraceptive Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Female Contraceptive Market Facts & Figures by Country

3.6.1 Asia Pacific Female Contraceptive Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Female Contraceptive Sales by Country (2019-2030)

3.6.3 Asia Pacific Female Contraceptive Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Female Contraceptive Market Facts & Figures by Country

3.7.1 Latin America Female Contraceptive Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Female Contraceptive Sales by Country (2019-2030)

3.7.3 Latin America Female Contraceptive Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Female Contraceptive Market Facts & Figures by Country

3.8.1 Middle East and Africa Female Contraceptive Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Female Contraceptive Sales by Country (2019-2030)

3.8.3 Middle East and Africa Female Contraceptive Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Female Contraceptive Sales by Type (2019-2030)

4.1.1 Global Female Contraceptive Sales by Type (2019-2024)

4.1.2 Global Female Contraceptive Sales by Type (2025-2030)

4.1.3 Global Female Contraceptive Sales Market Share by Type (2019-2030)

4.2 Global Female Contraceptive Revenue by Type (2019-2030)

4.2.1 Global Female Contraceptive Revenue by Type (2019-2024)

4.2.2 Global Female Contraceptive Revenue by Type (2025-2030)

4.2.3 Global Female Contraceptive Revenue Market Share by Type (2019-2030)

4.3 Global Female Contraceptive Price by Type (2019-2030)

5 Segment by Application

5.1 Global Female Contraceptive Sales by Application (2019-2030)

5.1.1 Global Female Contraceptive Sales by Application (2019-2024)

5.1.2 Global Female Contraceptive Sales by Application (2025-2030)

5.1.3 Global Female Contraceptive Sales Market Share by Application (2019-2030)

5.2 Global Female Contraceptive Revenue by Application (2019-2030)

5.2.1 Global Female Contraceptive Revenue by Application (2019-2024)

5.2.2 Global Female Contraceptive Revenue by Application (2025-2030)

5.2.3 Global Female Contraceptive Revenue Market Share by Application (2019-2030)

5.3 Global Female Contraceptive Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Female Contraceptive Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Female Contraceptive Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Allergan

6.3.1 Allergan Corporation Information

6.3.2 Allergan Description and Business Overview

6.3.3 Allergan Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Allergan Female Contraceptive Product Portfolio

6.3.5 Allergan Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer Female Contraceptive Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 Okamoto Industries

6.5.1 Okamoto Industries Corporation Information

6.5.2 Okamoto Industries Description and Business Overview

6.5.3 Okamoto Industries Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Okamoto Industries Female Contraceptive Product Portfolio

6.5.5 Okamoto Industries Recent Developments/Updates

6.6 Reckitt Benckiser

6.6.1 Reckitt Benckiser Corporation Information

6.6.2 Reckitt Benckiser Description and Business Overview

6.6.3 Reckitt Benckiser Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Reckitt Benckiser Female Contraceptive Product Portfolio

6.6.5 Reckitt Benckiser Recent Developments/Updates

6.7 Lupin Pharmaceuticals

6.6.1 Lupin Pharmaceuticals Corporation Information

6.6.2 Lupin Pharmaceuticals Description and Business Overview

6.6.3 Lupin Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lupin Pharmaceuticals Female Contraceptive Product Portfolio

6.7.5 Lupin Pharmaceuticals Recent Developments/Updates

6.8 Foundation Consumer Healthcare

6.8.1 Foundation Consumer Healthcare Corporation Information

6.8.2 Foundation Consumer Healthcare Description and Business Overview

6.8.3 Foundation Consumer Healthcare Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Foundation Consumer Healthcare Female Contraceptive Product Portfolio

6.8.5 Foundation Consumer Healthcare Recent Developments/Updates

6.9 Teva Pharmaceuticals

6.9.1 Teva Pharmaceuticals Corporation Information

6.9.2 Teva Pharmaceuticals Description and Business Overview

6.9.3 Teva Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Teva Pharmaceuticals Female Contraceptive Product Portfolio

6.9.5 Teva Pharmaceuticals Recent Developments/Updates

6.10 Ansell

6.10.1 Ansell Corporation Information

6.10.2 Ansell Description and Business Overview

6.10.3 Ansell Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Ansell Female Contraceptive Product Portfolio

6.10.5 Ansell Recent Developments/Updates

6.11 Ferring Pharmaceuticals

6.11.1 Ferring Pharmaceuticals Corporation Information

6.11.2 Ferring Pharmaceuticals Female Contraceptive Description and Business Overview

6.11.3 Ferring Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Ferring Pharmaceuticals Female Contraceptive Product Portfolio

6.11.5 Ferring Pharmaceuticals Recent Developments/Updates

6.12 Fuji Latex

6.12.1 Fuji Latex Corporation Information

6.12.2 Fuji Latex Female Contraceptive Description and Business Overview

6.12.3 Fuji Latex Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Fuji Latex Female Contraceptive Product Portfolio

6.12.5 Fuji Latex Recent Developments/Updates

6.13 Janssen Pharmaceuticals

6.13.1 Janssen Pharmaceuticals Corporation Information

6.13.2 Janssen Pharmaceuticals Female Contraceptive Description and Business Overview

6.13.3 Janssen Pharmaceuticals Female Contraceptive Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Janssen Pharmaceuticals Female Contraceptive Product Portfolio

6.13.5 Janssen Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Female Contraceptive Industry Chain Analysis

7.2 Female Contraceptive Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Female Contraceptive Production Mode & Process

7.4 Female Contraceptive Sales and Marketing

7.4.1 Female Contraceptive Sales Channels

7.4.2 Female Contraceptive Distributors

7.5 Female Contraceptive Customers

8 Female Contraceptive Market Dynamics

8.1 Female Contraceptive Industry Trends

8.2 Female Contraceptive Market Drivers

8.3 Female Contraceptive Market Challenges

8.4 Female Contraceptive Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Lupin Pharmaceuticals

Foundation Consumer Healthcare

Teva Pharmaceuticals

Ansell

Ferring Pharmaceuticals

Fuji Latex

Janssen Pharmaceuticals

List of Tables

Table 1. Global Female Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Female Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Female Contraceptive Market Competitive Situation by Manufacturers in 2023

Table 4. Global Female Contraceptive Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Female Contraceptive Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Female Contraceptive Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Female Contraceptive Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Female Contraceptive Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Female Contraceptive, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Female Contraceptive, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Female Contraceptive, Product Type & Application

Table 12. Global Key Manufacturers of Female Contraceptive, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Female Contraceptive by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Female Contraceptive as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Female Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Female Contraceptive Sales by Region (2019-2024) & (K Units)

Table 18. Global Female Contraceptive Sales Market Share by Region (2019-2024)

Table 19. Global Female Contraceptive Sales by Region (2025-2030) & (K Units)

Table 20. Global Female Contraceptive Sales Market Share by Region (2025-2030)

Table 21. Global Female Contraceptive Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Female Contraceptive Revenue Market Share by Region (2019-2024)

Table 23. Global Female Contraceptive Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Female Contraceptive Revenue Market Share by Region (2025-2030)

Table 25. North America Female Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Female Contraceptive Sales by Country (2019-2024) & (K Units)

Table 27. North America Female Contraceptive Sales by Country (2025-2030) & (K Units)

Table 28. North America Female Contraceptive Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Female Contraceptive Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Female Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Female Contraceptive Sales by Country (2019-2024) & (K Units)

Table 32. Europe Female Contraceptive Sales by Country (2025-2030) & (K Units)

Table 33. Europe Female Contraceptive Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Female Contraceptive Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Female Contraceptive Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Female Contraceptive Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Female Contraceptive Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Female Contraceptive Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Female Contraceptive Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Female Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Female Contraceptive Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Female Contraceptive Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Female Contraceptive Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Female Contraceptive Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Female Contraceptive Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Female Contraceptive Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Female Contraceptive Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Female Contraceptive Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Female Contraceptive Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Female Contraceptive Sales (K Units) by Type (2019-2024)

Table 51. Global Female Contraceptive Sales (K Units) by Type (2025-2030)

Table 52. Global Female Contraceptive Sales Market Share by Type (2019-2024)

Table 53. Global Female Contraceptive Sales Market Share by Type (2025-2030)

Table 54. Global Female Contraceptive Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Female Contraceptive Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Female Contraceptive Revenue Market Share by Type (2019-2024)

Table 57. Global Female Contraceptive Revenue Market Share by Type (2025-2030)

Table 58. Global Female Contraceptive Price (USD/Unit) by Type (2019-2024)

Table 59. Global Female Contraceptive Price (USD/Unit) by Type (2025-2030)

Table 60. Global Female Contraceptive Sales (K Units) by Application (2019-2024)

Table 61. Global Female Contraceptive Sales (K Units) by Application (2025-2030)

Table 62. Global Female Contraceptive Sales Market Share by Application (2019-2024)

Table 63. Global Female Contraceptive Sales Market Share by Application (2025-2030)

Table 64. Global Female Contraceptive Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Female Contraceptive Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Female Contraceptive Revenue Market Share by Application (2019-2024)

Table 67. Global Female Contraceptive Revenue Market Share by Application (2025-2030)

Table 68. Global Female Contraceptive Price (USD/Unit) by Application (2019-2024)

Table 69. Global Female Contraceptive Price (USD/Unit) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Merck Female Contraceptive Product

Table 74. Merck Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Pfizer Female Contraceptive Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Allergan Corporation Information

Table 81. Allergan Description and Business Overview

Table 82. Allergan Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Allergan Female Contraceptive Product

Table 84. Allergan Recent Developments/Updates

Table 85. Bayer Corporation Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Bayer Female Contraceptive Product

Table 89. Bayer Recent Developments/Updates

Table 90. Okamoto Industries Corporation Information

Table 91. Okamoto Industries Description and Business Overview

Table 92. Okamoto Industries Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Okamoto Industries Female Contraceptive Product

Table 94. Okamoto Industries Recent Developments/Updates

Table 95. Reckitt Benckiser Corporation Information

Table 96. Reckitt Benckiser Description and Business Overview

Table 97. Reckitt Benckiser Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. Reckitt Benckiser Female Contraceptive Product

Table 99. Reckitt Benckiser Recent Developments/Updates

Table 100. Lupin Pharmaceuticals Corporation Information

Table 101. Lupin Pharmaceuticals Description and Business Overview

Table 102. Lupin Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Lupin Pharmaceuticals Female Contraceptive Product

Table 104. Lupin Pharmaceuticals Recent Developments/Updates

Table 105. Foundation Consumer Healthcare Corporation Information

Table 106. Foundation Consumer Healthcare Description and Business Overview

Table 107. Foundation Consumer Healthcare Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Foundation Consumer Healthcare Female Contraceptive Product

Table 109. Foundation Consumer Healthcare Recent Developments/Updates

Table 110. Teva Pharmaceuticals Corporation Information

Table 111. Teva Pharmaceuticals Description and Business Overview

Table 112. Teva Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Teva Pharmaceuticals Female Contraceptive Product

Table 114. Teva Pharmaceuticals Recent Developments/Updates

Table 115. Ansell Corporation Information

Table 116. Ansell Description and Business Overview

Table 117. Ansell Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Ansell Female Contraceptive Product

Table 119. Ansell Recent Developments/Updates

Table 120. Ferring Pharmaceuticals Corporation Information

Table 121. Ferring Pharmaceuticals Description and Business Overview

Table 122. Ferring Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 123. Ferring Pharmaceuticals Female Contraceptive Product

Table 124. Ferring Pharmaceuticals Recent Developments/Updates

Table 125. Fuji Latex Corporation Information

Table 126. Fuji Latex Description and Business Overview

Table 127. Fuji Latex Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 128. Fuji Latex Female Contraceptive Product

Table 129. Fuji Latex Recent Developments/Updates

Table 130. Janssen Pharmaceuticals Corporation Information

Table 131. Janssen Pharmaceuticals Description and Business Overview

Table 132. Janssen Pharmaceuticals Female Contraceptive Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 133. Janssen Pharmaceuticals Female Contraceptive Product

Table 134. Janssen Pharmaceuticals Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Female Contraceptive Distributors List

Table 138. Female Contraceptive Customers List

Table 139. Female Contraceptive Market Trends

Table 140. Female Contraceptive Market Drivers

Table 141. Female Contraceptive Market Challenges

Table 142. Female Contraceptive Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Female Contraceptive

Figure 2. Global Female Contraceptive Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Female Contraceptive Market Share by Type in 2023 & 2030

Figure 4. Female Contraceptive Devices Product Picture

Figure 5. Female Contraceptive Drugs Product Picture

Figure 6. Global Female Contraceptive Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Female Contraceptive Market Share by Application in 2023 & 2030

Figure 8. Online Stores

Figure 9. Retail Outlets

Figure 10. Global Female Contraceptive Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Female Contraceptive Market Size (2019-2030) & (US$ Million)

Figure 12. Global Female Contraceptive Sales (2019-2030) & (K Units)

Figure 13. Global Female Contraceptive Average Price (USD/Unit) & (2019-2030)

Figure 14. Female Contraceptive Report Years Considered

Figure 15. Female Contraceptive Sales Share by Manufacturers in 2023

Figure 16. Global Female Contraceptive Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Female Contraceptive Players: Market Share by Revenue in 2023

Figure 18. Female Contraceptive Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Female Contraceptive Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Female Contraceptive Sales Market Share by Country (2019-2030)

Figure 21. North America Female Contraceptive Revenue Market Share by Country (2019-2030)

Figure 22. U.S. Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Female Contraceptive Sales Market Share by Country (2019-2030)

Figure 25. Europe Female Contraceptive Revenue Market Share by Country (2019-2030)

Figure 26. Germany Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Female Contraceptive Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Female Contraceptive Revenue Market Share by Region (2019-2030)

Figure 33. China Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Taiwan Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Indonesia Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Thailand Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Malaysia Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Philippines Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Latin America Female Contraceptive Sales Market Share by Country (2019-2030)

Figure 44. Latin America Female Contraceptive Revenue Market Share by Country (2019-2030)

Figure 45. Mexico Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Middle East & Africa Female Contraceptive Sales Market Share by Country (2019-2030)

Figure 49. Middle East & Africa Female Contraceptive Revenue Market Share by Country (2019-2030)

Figure 50. Turkey Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Saudi Arabia Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. UAE Female Contraceptive Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Global Sales Market Share of Female Contraceptive by Type (2019-2030)

Figure 54. Global Revenue Market Share of Female Contraceptive by Type (2019-2030)

Figure 55. Global Female Contraceptive Price (USD/Unit) by Type (2019-2030)

Figure 56. Global Sales Market Share of Female Contraceptive by Application (2019-2030)

Figure 57. Global Revenue Market Share of Female Contraceptive by Application (2019-2030)

Figure 58. Global Female Contraceptive Price (USD/Unit) by Application (2019-2030)

Figure 59. Female Contraceptive Value Chain

Figure 60. Female Contraceptive Production Process

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Distributors Profiles

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Surrogacy Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3H6190

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Combined Hormonal Contraceptive Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3P9630

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Male Infertility Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Y5897

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Oxytocin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35A3544

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions